portal hypertension, esophageal varices, liver diseases
Conditions
Interventions
A group of 69 patients with portal hypertension, aged 0 to 15 years, will be submitted to clinical follow-up, starting in 2014, comprising clinical evaluation, collection of laboratory tests, blood co
Other
SP4.006.057.488.709
Sponsors
Departamento de Cirurgia e Ortopedia da Faculdade de Medicina de Botucatu
Unesp-Universidade Estadual Julio de Mesquita-Faculdade de Medicina de Botucatu
Eligibility
Age
1 Months to 15 Years
Inclusion criteria
Inclusion criteria: patients with up to 15 years of age; in follow-up by portal hypertension of any etiology; that are not in use of beta-blocker;to agree to the free and informed consent of the parents or guardians and the of 12 years.
Exclusion criteria
Exclusion criteria: the use of beta-blocker, previous high gastrointestinal bleeding, having undergone portosystemic shunts or TIPS (intra-hepatic transjugular shunt), liver transplantation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Identification of esophageal varices in children with portal hypertension, diagnosed by upper digestive endoscopy, classified by Palmer & Bricks (1956). | — |
Secondary
| Measure | Time frame |
|---|---|
| Identification of the presence of endoscopic signs suggestive of hypertensive gastropathy, diagnosed by upper digestive endoscopy, classified as mild / moderate or severe. | — |
Countries
Brazil
Contacts
Public ContactJuliana Dias
Unesp-Universidade Estadual Julio de Mesquita-Faculdade de Medicina de Botucatu
Outcome results
None listed